Skip to main content

Table 2 Correlation coefficients between the metabolic response in breast and axilla with different SUVmax variables according to subtype

From: Additional value of 18F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer

 

TN

(n = 45)

HER2+

(n = 60)

median

(IQR)

r

median

(IQR)

r

SUVmax PET1

 Breast

10.7

(6.5 – 16.5)

0.42

6.8

(4.7 – 9.3)

0.38

 Axilla

8.0

(4.9 – 13.8)

 

5.3

(3.3 – 7.6)

 

SUVmax PET2

 Breast

7.9

(5.1 – 10.0)

0.36

2.8

(2.2 – 3.6)

0.49

 Axilla

4.2

(3.1 – 7.2)

 

2.1

(1.7 – 2.5)

 

SUVmax PET3

 Breast

3.5

(2.5 – 5.0)

0.33

2.0

(1.5 – 2.4)

0.14

 Axilla

2.1

(1.3 – 3.6)

 

1.7

(1.3 – 2.4)

 

ΔSUVmax (%) PET1-PET2

 Breast

-32%

(-49 – -16)

0.49

-56%

(-68 – -47)

0.30

 Axilla

-33%

(-58 – -13)

 

-56%

(-70 – -38)

 

ΔSUVmax (%) PET1-PET3

 Breast

-67%

(-77 – -49)

0.57

-69%

(-78 – -52)

0.27

 Axilla

-70%

(-84 – -48)

 

-66%

(-79 – -50)

 
  1. TN triple-negative, HER2+ HER2-positive, n number of patients, IQR interquartile range, r Spearman’s correlation coefficient